当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第5期
编号:13425649
非特异性免疫疗法在支气管哮喘治疗中的应用进展(6)
http://www.100md.com 2019年2月5日 《医学信息》 2019年第5期
     [37]Kuribayashi K,Kodama T,Okamara H,et al.Effects of post-inhalation treatment with interleukin-12 on airway hyper-reactivity,eosinophilia and interleukin-18 receptor expression ina mouse model of asthma[J].Clin Exp Allergy,2002(32):641-649.

    [38]Zhou E,Fu Y,Wei Z,et al.Inhibition of allergic airway inflammation through the blockage of NF-κB activation by ellagic acid in an ovalbumin-induced mouse asthma model[J].Food Funct,2014,5(9):2106-2112.

    [39]Bakkourik E,Wullaert A,Haegman M,et al.Adenoviral gene transfer of the NF-κB inhibitory protein abin-1 decreases allergic airway inflammation in a murine asthma model[J].J Biol Chem,2005,280(18):17938-17944.

    [40]Krishnamurthy P,Kaplan MH.STAT6 and PARP Family Members in the Development of T Cell-dependent Allergic Inflammation[J].Immune Netw,2016,16(4):201-210.

    [41]Mc Cracken JL,Veeranki SP,Ameredes BT,et al.Diagnosis and Management of Asthma in Adults: A Review [J].JAMA,2017,318(3):279-290.

    [42]Rayees S,Malik F,Bukhari SI,et al.Linking GATA-3 and interleukin-13:implications in asthma[J].Inflamm Res,2014,63(4):255-265.

    收稿日期:2018-12-17;修回日期:2018-12-28

    編辑/王朵梅, http://www.100md.com(王晓燕 梁萍 董艳婷)
上一页1 2 3 4 5 6